Evaluation of Prototype Cell Delivery Catheters Using Agarose Gel and Cell Culture Experiments by Panse, Sagar
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2006
Evaluation of Prototype Cell Delivery Catheters
Using Agarose Gel and Cell Culture Experiments
Sagar Panse
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Biomedical Engineering and Bioengineering Commons
© The Author
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses
and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/904
 © Sagar Panse 2006  
All Rights Reserved 
 
 Evaluation of Prototype Cell Delivery Catheters Using Agarose Gel and Cell Culture 
Experiments 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
by 
 
SAGAR PANSE MBBS 
Bharati Vidyapeeth’s Medical College, India, 2001 
 
 
Director: Dr. HELEN FILLMORE  
ASSOCIATE PROFESSOR OF NEUROSURGERY 
 
 
 
 
 
 
 
 
 
Virginia Commonwealth University 
Richmond, Virginia 
 December 2006 
 
 
                   
 ii
  Table of Contents 
Page 
List of Tables .................................................................................................................... IV 
List of Figures .....................................................................................................................V 
Chapter 
1 Introduction........................................................................................................1 
Parkinson’s disease........................................................................................2 
Alzheimer’s disease.......................................................................................4 
Glioblastoma multiforme ..............................................................................5 
Intra-cranial therapy ......................................................................................6 
Prototype cell delivery catheters ...................................................................8 
Specific aims ...............................................................................................10 
 
2 Material and Methods ......................................................................................11 
Prototype cell delivery catheters .................................................................11 
Agarose gel preparation...............................................................................13 
Brainbox ......................................................................................................13 
Navigus trajectory guide .............................................................................13 
Collagen gel preparation .............................................................................14 
Sandwich gel preparation ............................................................................14 
Bromophenol Blue dye................................................................................14 
 iii
Pheochromocytoma cells.............................................................................15 
Neural growth factor ...................................................................................15 
Statistics.......................................................................................................16 
Dye experiments..........................................................................................16 
Cell culture experiments with 25-gauge syringe needle .............................20 
Cell culture experiments with prototype catheters ......................................25 
 
3 Results..............................................................................................................30 
Dye experiments with 1.6 mm small bore catheter .....................................30 
Dye experiments with 2.0 mm large bore catheter......................................38 
Cell culture experiments with 25-gauge syringe needle .............................47 
Cell culture experiments with small and large bore catheters.....................53 
Neural Growth Factor..................................................................................56 
 
4 Discussion and Conclusion ..............................................................................58 
Discussion ...................................................................................................58 
Conclusion...................................................................................................63 
References..........................................................................................................................65 
Vita.....................................................................................................................................70 
 
 iv
List of Tables 
Page 
Table 1: Dye experiments with 1.6 mm small bore catheter. ............................................18 
Table 2: Dye experiments with 2.0 mm large bore catheter. .............................................19 
Table 3: Cell culture experiments using 25 gauge syringe needle and prototype cell 
delivery catheters. ..............................................................................................................29 
Table 4: Results of dye experiments with 1.6 mm small bore catheter. ............................36 
Table 5: Graph of results of dye experiments with 1.6 mm small bore catheter. ..............37 
Table 6: Results of dye experiments with 2.0 mm large bore catheter with inner tube 
filled with dye and inserted with outer tube into gel .........................................................39 
Table 7: Results of dye experiments with 2.0 mm large bore catheter with outer tube 
inserted in gel and then dye filled inner tube.....................................................................41 
Table 8: Results of dye experiments with 2.0 mm large bore catheter with both inner and 
outer tubes inserted in gel and filled with dye ...................................................................44 
Table 9: Graph of dye experiments with 2.0 mm large bore catheter................................46 
 
 
 
 
 
 
 v
List of Figures 
Page 
Figure 1: Prototype cell delivery catheters ........................................................................12 
Figure 2: Tubes of the prototype cell delivery catheters....................................................12 
Figure 3: 12 well plate with vertically placed guide cannulae...........................................22 
Figure 4: Closer view of 25 gauge syringe needle infusion through vertically placed guide 
cannula ...............................................................................................................................23 
Figure 5: Cell culture insert with laterally implanted guide cannula.................................24 
Figure 6: Infusion assembly with 2.0 mm large bore catheter and cell culture insert .......27 
Figure 7: Closer view of 2.0 mm large bore catheter tip in cell culture insert ..................28 
Figure 8: Results of dye experiments with 1.6 mm small bore catheter............................32 
Figure 9: Results of dye experiments with 1.6 mm small bore catheter............................34 
Figure 10: Results of dye experiments with 2.0 mm large bore catheter ..........................42 
Figure 11: Results of dye experiments with 2.0 mm large bore catheter ..........................45 
Figure 12: Infusion of PC12 cells by 25 gauge needle in collagen gel (day1) ..................48 
Figure 13: Infusion of PC12 cells by 25 gauge needle in collagen gel (day3) ..................48 
Figure 14: Infusion of PC12 cells by 25 gauge needle in collagen gel (day7) ..................48 
Figure 15: Infusion of PC12 cells by 25 gauge needle passed through vertical guide 
cannula (day1)....................................................................................................................50 
Figure 16: Infusion of PC12 cells by 25 gauge needle passed through vertical guide 
cannula (day 3)...................................................................................................................50 
 vi
Figure 17: Infusion of PC12 cells by 25 gauge needle passed through vertical guide 
cannula (day 7)...................................................................................................................50 
Figure 18: Infusion of PC12 cells by 25 gauge needle passed through laterally implanted 
guide cannula (day 1).........................................................................................................52 
Figure 19: Infusion of PC12 cells by 25 gauge needle passed through laterally implanted 
guide cannula (day 7).........................................................................................................52 
Figure 20: Large bore catheter infusion of PC12 cells with agarose gel on top of collagen 
gel (day 1) ..........................................................................................................................55 
Figure 21: Large bore catheter infusion of PC12 cells with agarose gel on top of collagen 
gel (day 3) ..........................................................................................................................55 
Figure 22: Large bore catheter infusion of PC12 cells with agarose gel on top of collagen 
gel (day 7) ..........................................................................................................................55 
Figure 23: NGF added to sandwich gel after infusing PC 12 cells by prototype catheters 
( day 1) ..............................................................................................................................57 
Figure 24: NGF added to sandwich gel after infusing PC 12 cells by prototype catheters 
( day 4) ..............................................................................................................................57 
Figure 25:  No NGF added to sandwich gel after infusing PC 12 cells by prototype 
catheters (day4) .................................................................................................................57  
 
  
 vii
Abstract 
 
 
 
EVALUATION OF PROTOTYPE CELL DELIVERY CATHETERS USING 
AGAROSE GEL AND CELL CULTURE EXPERIMENTS 
By Sagar Panse, MBBS 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2006 
 
Major Director:  Helen Fillmore Ph.D. 
Associate Professor of Neurosurgery 
 
 
 
Neurodegenerative diseases and brain tumors affect millions of patients worldwide and 
are associated with significant morbidity and mortality. The blood brain barrier 
constitutes a major obstacle to delivery of therapeutic agents administered systemically 
for treating these disorders. Intracranial drug delivery provides a novel way of bypassing 
the blood brain barrier and achieving high concentration of therapeutic agents in the brain 
while avoiding systemic side effects. However damage to tissues during insertion of 
catheters, release of air in the brain and consequent backtracking of dye are some 
disadvantages with this mode of treatment. We evaluated prototype cell delivery catheters 
 viii
(each with outer and inner catheter) developed to minimize these complications. The 
catheters (1.6 mm small bore and 2.0 mm large bore) were evaluated using agarose gel 
and cell culture experiments. We initially delivered pheochromocytoma (PC 12) cells 
through a 25-gauge syringe needle to optimize characteristics for cell growth. We 
observed by the agarose gel experiments that when the inner catheter was filled and then 
inserted with the outer catheter, no air bubble or backtracking of dye was seen. PC 12 
cells delivered through the prototype catheters showed growth in collagen gel and 
differentiated into neurons in the presence of neural growth factor. Future studies with 
animal experiments would be needed to confirm the findings. 
  
 
 
 
 I Introduction 
 
 
 
Millions of people worldwide suffer from neurodegenerative disorders and 
movement disorders, principally Parkinson’s disease and Alzheimer’s disease. Most of 
these illnesses manifest themselves later in life. Therefore, correlated to the increase in 
life expectancy, the number of people affected with these diseases will grow (1).  These 
diseases are a major cause of morbidity. Another major cause of morbidity and mortality 
are brain tumors (2). The incidence rate of all primary benign and malignant brain tumors 
is 14.0 cases per 100,000 person-years (5.7 per 100,000 person-years for benign tumors 
and 7.7 per 100,000 person-years for malignant tumors).   
The brain is a very delicate organ. Unfortunately, the same mechanisms that 
protect it against intrusive chemicals can also frustrate therapeutic interventions. Many 
existing pharmaceuticals are rendered ineffective in the treatment of cerebral diseases due 
to our inability to effectively deliver and sustain them within the brain (3). The blood 
brain barrier (BBB), which is formed by tight junctions of endothelial cells that make up 
the walls of capillaries within the brain, is almost always a major “obstacle” to the 
delivery of therapeutic agents administered systemically into the brain. BBB prevents 
most hydrophilic drugs or drugs of moderate molecular weight from diffusing into the 
interstitial space of the brain (4).  Currently many strategies for the transient alteration of 
the BBB are under investigation but there is as yet no universally accepted means of 
1 
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accomplishing that task. As a result many diseases of the CNS including 
neurodegenerative diseases and brain tumors are left inadequately treated by existing 
therapies. These diseases may benefit from intracranial drug, growth factor, and growth 
inhibitor therapy (5). Intracranial therapy is advantageous as it delivers drugs directly into 
the affected brain region thereby minimizing the systemic side effects seen with 
traditional administration of drugs. The diseases likely to benefit from intracranial drug 
therapy are Parkinson’s disease, Alzheimer’s disease and brain tumors. 
 
1.1 Parkinson’s Disease 
Parkinson disease (PD) is a progressive neurodegenerative disorder associated 
with a loss of dopaminergic nigrostriatal neurons. PD is recognized as one of the most 
common neurological disorders. The major neuropathologic findings in PD are a loss of 
pigmented dopaminergic neurons in the substantia nigra and the presence of Lewy 
bodies. The loss of dopaminergic neurons occurs most prominently in the ventral lateral 
substantia nigra. The three cardinal signs of PD are resting tremor, rigidity, and 
bradykinesia. Most cases of idiopathic PD are believed to be due to a combination of 
genetic and environmental factors (reviewed in 6).  
The goal of medical management of PD is to provide control of signs and 
symptoms for as long as possible while minimizing adverse effects. Medications usually 
provide good symptomatic control for four to five years. After this, disability progresses 
despite best medical management, and many patients develop long-term motor 
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complications (7, 8). Additional causes of disability in late disease include postural 
instability (balance difficulty) and dementia.  
Several surgical procedures have been studied in advanced Parkinson's disease (PD), 
including deep brain stimulation (DBS), thalamotomy, and pallidotomy (9). 
Thalamotomy and chronic thalamic stimulation are effective in reducing medically 
refractory tremor (10). Stereotactic surgery has made resurgence in the treatment of PD. 
Deep brain stimulation of the subthalamic nucleus has been shown to be an effective 
therapeutic option for well-selected patients with medically intractable symptoms of 
Parkinson's disease (11, 12, 13).  Neural transplantation is a potential treatment for PD 
because the neuronal degeneration is site and type specific (ie, dopaminergic), the target 
area is well defined (ie, striatum), postsynaptic receptors are relatively intact, and the 
neurons provide tonic stimulation of the receptors and appear to serve a modulatory 
function (14).  Multiple sources of dopamine-producing cells, including fetal nigral cells, 
sympathetic ganglia, carotid body glomus cells, PC-12 cells, and neuroblastoma cells, 
have been studied. Results have been varied (14,15). 
Recently, Hauser et al reported promising results for 2-year follow-up for 6 patients with 
PD who underwent bilateral fetal nigral transplantation. Prospective, blinded, randomized 
studies are being performed to evaluate the long-term safety and efficacy of fetal nigral 
transplantation in patients with PD (16). Transplantation of fetal porcine cells in patients 
with advanced PD is now under study. In the laboratory, genetic engineering of cells and 
the use of stem cells are being investigated (17, 18). 
 
 4
1.2 Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common cause of dementia, which is an 
acquired cognitive and behavioral impairment of sufficient severity to interfere 
significantly with social and occupational functioning. At present, the disorder afflicts 
approximately 5 million people in the United States and more than 30 million people 
worldwide (19).  
The anatomic pathology of AD includes cerebrocortical atrophy (predominantly 
at the expense of association regions), and neurofibrillary tangles (NFTs) and senile 
plaques (SPs) at the microscopic level (20). In addition to NFTs and SPs (composed of 
amyloid protein), many other lesions of AD have been recognized since Alzheimer's 
original papers. The pathophysiological mechanism underlying the clinical 
manifestations of AD is corticocortical disconnection due to the loss of medium-sized 
pyramidal neurons effecting such connections (21). Clinical features are mainly due to 
cell deterioration in the forebrain cholinergic projection system, particularly, in a 
structure called nucleus basalis of Meynert (22). The earliest evidence of AD is the onset 
of chronic, insidious memory loss that is slowly progressive over several years. This can 
be associated with slowly progressive behavioral changes. Diffuse cortical/cerebral 
atrophy is expected to occur and can be seen on brain MRI or CT scans.  A variety of 
both behavioral and pharmacologic interventions have been shown to be useful in the 
management of AD, although their impact is often modest and temporary and does not 
prevent the eventual relentless deterioration of the patient's condition (23). 
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Neural stem cell (NSC) grafts present a potential and innovative strategy for the 
treatment of many disorders of the central nervous system including AD, with the 
possibility of providing a more permanent remedy than present drug treatments. After 
grafting, these cells have the capacity to migrate to lesioned regions of the brain and 
differentiate into the necessary type of cells that are lacking in the diseased brain, 
supplying it with the cell population needed to promote recovery (24, 25).  
 
1.3 Glioblastoma multiforme (GBM) 
GBM is the most common and most aggressive of the primary brain tumors. It is 
highly malignant, infiltrates the brain extensively, and at times may become massive 
before turning symptomatic (26).  
GBM is an anaplastic, highly cellular tumor with poorly differentiated, round, or 
pleomorphic cells, occasional multinucleated cells, nuclear atypia, and anaplasia. 
Presenting features include headaches, seizures and focal neurological deficits (27). 
Various genetic and molecular abnormalities have been identified. Primary GBM 
develops in older patients and demonstrates epidermal growth factor receptor over 
expression, MMAC1 mutations, CDKN2A deletions, and, less frequently, MDM2 
amplifications. Secondary GBM develops in younger patients and contains TP53 
mutations (28, 29).  
Available treatment options are surgery, radiotherapy, and chemotherapy (30). 
Removal and resection of GBM by neurosurgery is mostly incomplete due to the highly 
infiltrating nature of the tumor (31, 32). Newer modalities of treatment, which are under 
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investigation, include immunotherapy, antiangiogenesis targeting therapies, biologic 
therapy, gene therapy and growth factor and second messenger inhibition (33, 34). Many 
of these modalities would benefit with by utilizing intracranial therapy. 
 
1.4 Intracranial Therapy 
Many neural diseases including those mentioned above would benefit from 
intracranial delivery of drug, chemotherapeutic, growth inhibiting or stimulating factors. 
The most direct way of circumventing the BBB is to deliver drugs directly to the brain 
interstitium (35).  
Several techniques have been developed for delivering drugs directly to the brain 
interstitium. Implantable miniature osmotic pumps have been used to provide a 
continuous supply of drugs or other active biologic factors to the brain and other tissues 
at a controlled rate. Reservoir limitations as well as drug solubility and stability have, 
however, restricted the usefulness of this technology. Macroencapsulation, which 
generally involves loading cells into hollow fibers, then sealing the ends of the fibers and 
surgically implanting the cell culture device in the brain, has also been used to deliver 
therapeutic drugs into the central nervous system. However results with this technique 
have been unreliable (36). Implantable microporous devices that contain hormone 
releasing cells have been utilized with variable results. Thus, there exists a need for an 
improved method to deliver cells that can produce biologically active factors to a target 
region of the brain (36). 
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Convection-enhanced delivery (CED) via positive pressure infusion through catheters is 
evolving as a technique for site-specific drug delivery bypassing the BBB. Protocols for 
CED are designed to deliver clinically useful volumes of therapeutic agents into a 
specific region of the brain in which adequate concentrations of the drug cannot 
otherwise be established via systemic delivery.  There is data on the delivery of solutions 
of macromolecules by this technique for the purposes of characterizing the distribution 
pattern and confirming the safety of the technique (37). 
 The major advantage of intracranial therapy is site-specific therapy that avoids 
systemic side effects. Intracranial drug delivery is however not without problems (36). 
The brain is a very delicate and compact structure. Vital centers are located in close 
proximity to each other. Inadvertent damage to a center can result in lifelong 
complications or death. One of the problems with neurosurgical catheters is release of air 
into the brain (37). When an empty tube is filled with liquid, the air in the tube must go 
somewhere, but it should not be pushed into the brain where it could cause a backwash of 
the therapeutic agent along the catheter track. This backtracking of dye can lead to 
decreased concentration of therapeutic agent at the delivery site and excess concentration 
at a non-intended area. Both these effects are undesired. The air released in the 
intracranial cavity itself might cause problems. If air enters in the systemic circulation it 
can result in local or distant embolism (38). Intracranial air can also exert pressure on 
tissues resulting in damage. Another problem with intracranial catheters is tissue damage 
during insertion of catheters. This cannot be avoided but can be minimized by decreasing 
the frequency of catheter insertion or removal (39, 40). 
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1.5 Prototype cell delivery catheters 
We used experimental models to evaluate prototype cell delivery catheters 
designed to minimize the above-mentioned complications. The new catheters are made of 
two catheters, one inside the other. The inner catheter has an end pore while the outer 
catheter has 4 spiral pores. The inner pore can be aligned with one of the spiral pores on 
the outer catheter. When any agent is to be delivered using the catheters, first the inner 
catheter is filled with the agent. When sufficient pressure has been generated by the 
weight of the column in the inner catheter, the agent starts flowing through the end pore 
of the inner catheter into the outer catheter and then through the spiral pores of the outer 
catheter to the outside.  Once the outer catheter is guided into place, the inner catheter can 
be primed with a therapeutic agent, such as a gene therapy or cellular mixture, and 
inserted into the outer catheter. Multiple combinations of priming the catheters and 
insertion are possible and are mentioned in detail under material and methods.  
As the smaller catheter goes in, air is displaced through the narrow space between 
the two catheters. This air can escape to the outside between the inner and outer catheters 
or pass through one of the spiral pores into the brain. The size of the spiral pores is 1 mm 
allowing only a small quantity of air to pass through.  A porthole at the end of the inner 
tube is aligned with one in the outer tube, allowing the therapeutic agent to flow into the 
brain and minimizing air leak. The inner catheter can be withdrawn and reloaded while 
the outer catheter remains in place. This eliminates the potential for tissue damage from 
reinsertion. The catheters were intended to be used for intracranial delivery of different 
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agents. We evaluated the catheters using two separate 3-dimensional gel models, a dye 
model and a cell culture model.  
The dye experiments were used to characterize leakage of air and backtracking of 
dye using the catheters.  Agarose gel at 0.6% concentration in TBE (Tris-Borate-EDTA) 
buffer closely resembles in vivo brain during infusion studies, with respect to several 
critical physical characteristics (41). Broaddus et al has shown that agarose gel (0.6%) 
serves as a workable surrogate for in vivo bulk mammalian brain tissue in exploratory 
studies of the intraparenchymal positive pressure infusion of therapeutic agents (42).  We 
used different combinations of catheters to inject bromophenol blue dye into the agarose 
gel. The dye as it passed into the gel was visualized. The presence and maximum two 
dimensions of the air bubble produced, if any, were measured in mm.  Backtracking of 
the dye was also noted.  
In the second set of experiments we delivered cells through prototype cell 
delivery catheters into collagen gel using a stereotactic assembly under aseptic 
conditions.  We used pheochromocytoma (PC12) cells for infusion. We first infused the 
cells through a 25-gauge needle syringe to study cell growth and distribution as well as 
NGF induced differentiation. After determining a favorable microenvironment for cell 
growth, we infused cells through the catheters into 4ml collagen gel and into a sandwich 
gel of 2 ml collagen and 2 ml agarose on the top.  Differentiation of cells after adding 
neural growth factor was observed and studied.  
The 0.6% agarose gel and collagen gel experiments revealed that the catheters 
could be used for experimental purposes for the delivery of dye and cells. When the inner 
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catheter was primed with therapeutic agent, inserted into the outer catheter and then into 
gel, minimal air leak and backtracking of dye were noted. Further studies including 
animal infusion studies are needed. If these studies reveal a favorable outcome, the 
catheters have a good potential in delivering intracranial agents. This will have a 
significant impact in the treatment of neurodegenerative diseases and brain tumors. 
 
1.6 Specific Aims 
Experiments were conducted to study the properties of prototype cell delivery 
catheters and their effectiveness for delivering different agents. This was done with 2 
groups of experiments with specific aims: 
1. Agarose gel model: To determine optimal combination of inner and outer 
catheters to eliminate air leak and backtracking of dye. 
2. Cell Culture model: To investigate the effect of delivery of cells into a 3-
dimensional gel using catheter combination found to be optimal in specific aim 1 
on cell growth and differentiation. 
 
 II Material and Methods 
 
 
 
2.1 Catheters 
 Prototype cell delivery catheters were evaluated. The catheters were obtained 
from Image Guided Neurologics, Melbourne, Florida. Each catheter has an inner and 
outer catheter (fig.1). The inner catheter has a terminal pore, while the outer catheter has 
4 spiral pores on the side. The terminal pore of the inner catheter could be aligned with 
one of the spiral pores of the outer catheter. For all experiments unless specified 
otherwise, the terminal pore was aligned with one of the spiral pores and the other three 
spiral pores were covered with tape. The maximum length of the outer catheter was 6 
inches and that of the inner catheter was 6.75 inches.  Two separate catheters that differed 
in the diameters of their outer and inner catheters were evaluated (fig. 2). The diameters 
of the outer catheters were 1.6 mm and 2.0 mm for the small bore and large bore 
catheters respectively. The diameter of the inner catheter of the small bore catheter was 
0.8 mm and of the large bore catheter was 1.0 mm. When the inner catheter was inserted 
into the outer catheter, an air column was present between the 2 catheters. This air could 
exit the system through the open spiral pore or through the gap between the inner and 
outer catheters.
11 
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Figure1. 2.0 mm large bore catheter (top) and 1.6 mm small 
bore catheter (bottom). Each catheter has inner and outer 
catheters. 
 
 
Figure 2. Inner and outer tubes of the catheters. The 1.6 mm 
small bore catheter is on the top and the 2.0 mm large bore 
catheter is at the bottom. 
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2.2 Agarose gel preparation 
 Agarose gel was prepared by mixing agarose powder and 1X TBE (89mM Tris, 
pH 8.4; 2mM EDTA) solution. The mixture was heated until all the powder had dissolved 
and boiled for 5 min. When the resulting solution had cooled to about 50°C, 
approximately 500 ml was poured into a rectangular container made of thin-walled 
transparent Plexiglas™ of dimensions 10 cm x 10 cm x 7 cm, to grossly simulate a large 
fraction of the volume of human brain (41). The agarose gel solidified as it cooled to 
room temperature.  This apparatus containing agarose gel is referred to as the brain box. 
 
2.3 Brain box  
            Chen et al. have shown that 0.6% agarose gel in the brain box grossly simulate the 
distribution characteristics of the human brain (41). Navigus trajectory guide was firmly 
attached to the detachable lid of the brain box. The transparent material of the brain box 
allowed good visualization of dye. 
 
2.4 Navigus 
  Navigus is a disposable magnetic resonance (MR)-compatible trajectory guide 
made from plastic. It was obtained from Image-Guided Neurologics, Melbourne, FL. The 
Navigus trajectory guide was mounted in the rectangular lid of the container and served 
as the insertion and guidance path for the catheter that would deliver the infusate into the 
gel (42, 43, 44).   
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2.5 Collagen gel preparation 
 The collagen gel was made by adding 8 ml of type I collagen solution (obtained 
from Vitrogen, Inc) and 1 ml of Minimal Essential Medium (MEM). 1ml of 0.1 N 
Sodium chloride was added drop by drop till the color changed to pink. The mixture was 
then spun at 4000 rpm for 6 minutes to remove any air bubbles. It was then poured into 4-
6 cell culture inserts that were placed in a 6 or 12 well cell culture plate. The collagen gel 
solidified in approximately 1-2 hours. The entire process was carried out under aseptic 
conditions. Collagen was used as it has been shown to support the growth of 
pheochromocytoma cells in cell cultures (45). 
 
2.6 Sandwich gel preparation 
 Collagen gel was prepared using the method mentioned in the above paragraph. 
Collagen gel (2 ml.) was added to 4-6 cell culture inserts that were placed in a 6 or 12 
well cell culture plate and allowed to solidify. Agarose gel was prepared as mentioned 
above. The gel was allowed to cool partially and before it could solidify it was added to 
the solidified collagen gel. The entire process was carried out under aseptic conditions. 
 
2.7 Bromophenol blue dye 
  Bromophenol blue dye was used for infusion during the agarose gel experiments. 
It has been shown that the blue color of the dye allows its easy visualization in the 
agarose gel (47). Chen et al have shown that the diffusion characteristics of bromophenol 
blue dye in agarose gel are similar to those in the brain (41). 
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2.8 Pheocromocytoma cells (PC12) 
 Pheochromocytoma cells obtained from rodents were used for cell culture 
experiments. PC12 cells were available as a cell culture suspension. These cells have the 
potential to differentiate into neurons in the presence of neural growth factor (47, 48, 49). 
The growth and differentiation of PC12 cells infused by the cell delivery catheters were 
studied. The cells were harvested each week to maintain viability. Before infusion the 
cells were harvested using the following protocol. The cell suspension was centrifuged at 
1000 rpm for 5 min. The supernatant was discarded and the cells were washed with 
Hanks Balanced Salt Solution to free the cells. The cell suspension was again centrifuged 
at 1000 rpm for 5 min. The supernatant was discarded and the cells were washed with 
RPMI (Roswell Park Memorial Institute) medium (50). The cells were then counted 
using a Neubar's chamber™. For cell infusion experiments a final cell concentration of 1 
million / cm³ was obtained by diluting with RPMI medium.  
 
2.9 Neural growth factor (NGF) 
  NGF is a neurotropic protein that plays a critical role in the development of 
sympathetic and some sensory neurons in the nervous system (51, 52). Recombinant 
NGF was obtained from R&D systems; Inc. NGF has been shown to favor differentiation 
of pheochromocytoma cells in cell cultures (53, 54).  
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2.10 Statistics 
        Size of air leak during dye experiments was compared using ANOVA analysis. 
Paired t test was also used for comparison. SPSS software was used to compute the 
statistics. A p value of less than 0.05 was considered significant.   
 
 
2.11 Dye Experiments 
 The 0.6 % agarose gel was prepared in the brain box. With the help of a Navigus 
trajectory guide, the catheters were inserted in the gel. Three combinations were possible 
for infusion of dye into agarose gel through the catheters: 
1. Inner catheter filled with dye and inserted into outer catheter and then into the gel 
2. Outer catheter inserted in gel and then dye filled inner catheter inserted in the outer 
catheter 
3. Both inner and outer catheters inserted in gel and then the inner catheter filled with 
dye. 
 The above sets of experiments were conducted with both the 1.6 mm small bore and 2.0 
mm large bore catheters (see table1). Each experiment with each catheter was repeated 
three times. For combination 2 and 3, with the 2.0 mm large bore catheter additional 
modifications were tested. The inner catheter fitted inside the outer catheter with 2 
possibilities. The inner catheter could be inserted into the outer catheter and then locked. 
Theoretically the locking mechanism will not allow air in the column between the inner 
and outer catheters to escape to the outside. The other possibility was to insert the inner 
catheter into the outer catheter and keep it unlocked. With the unlocked position of the 
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inner catheter, air in the column between the catheters will have the potential to escape 
outside and would not be forced to enter the gel (see table 2).  We wanted to test the 
hypothesis that the unlocked position of the inner and outer catheters would result in less 
significant air bubble formation in the gel and backtracking. 
 Using a three-way connector, the catheter was connected to a dye-filled syringe, 
which was mounted on a flow rate monitor. The flow rate monitor allowed infusion 
through the catheters at a fixed rate. The flow rate was kept constant at 1 μl / min for 1 
hour. Chen et al. reported that infusing bromophenol dye at a rate of 1 μl / min for 1 hour 
into agarose gel allows good visualization of dye as it passes through the catheter into the 
gel.  The infusion was started and bromophenol blue dye as it passed into the gel was 
visualized. The presence and maximum dimensions of the air bubble produced, if any, 
were measured in mm. The visible surface area of the air bubble was calculated as the 
product of the maximum dimensions.  Backtracking of the dye was also noted. The whole 
experiment was video recorded and digital pictures were taken at every 5-minute interval. 
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Table 1. Schematic representation of dye experiments performed using 
1.6 mm small bore catheter.  
 
 
Inner catheter filled with dye and inserted into outer catheter and then into the gel
Outer catheter inserted in gel and then dye filled inner catheter inserted in the outer catheter
Both inner and outer catheters inserted in gel and then the inner catheter filled with dye
 Dye experiments with 1.6 mm small bore catheter
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Table 2. Schematic representation of dye experiments performed using 2.0 mm 
large bore catheter. 
 Inner catheter filled with dye and inserted into outer catheter and then into the gel
Inner catheter locked Inner catheter unlocked
 Outer catheter inserted in gel and then dye filled inner catheter inserted in the outer catheter
Inner catheter locked Inner catheter unlocked
Both inner and outer catheters inserted in gel and then the inner catheter filled with dye
 Dye experiments with 2.0 mm large bore catheter
 
                                                                                                                                                   20
2.12 Cell Culture experiments 
2.12.1  Cell culture experiments using 25 gauge syringe needle 
 Infusion experiments with a 25-gauge syringe needle were conducted to study the 
baseline characteristics of cell infusion and growth in gel. The goal of these experiments 
was to optimize the conditions favorable for cell growth and visualization of cells in gel. 
 Collagen gel was prepared as mentioned above. Collagen (4 ml) was added to cell 
culture inserts of 6-12 well plates and allowed to solidify. The entire procedure was done 
in the hood with thorough aseptic measures. PC 12 cells were harvested as per the above- 
mentioned protocols. Cell count was made and diluted to achieve a cell count of 
approximately 1 million / cm³. The cell suspension was then filled in the 25 μl sterilized 
syringe needle. The syringe needle was attached to a flow rate monitor. The tip of the 25-
gauge syringe needle was inserted into the collagen gel in the cell culture insert, which 
was placed on a lab jack. The tip of the syringe needle was kept around 1.5 cm below the 
gel surface. The infusion was started and the flow rate was kept constant at 20 μl / min 
for a period of 3 minutes and then stopped. The tip of the needle was removed from the 
gel. The insert with the collagen gel was placed in the 6 or 12 well plate and incubated 
for 7 days. Cell growth in the gel was followed over 7 days under microscope and digital 
pictures were taken. 
 Another set of infusion experiments with the needle was performed to identify 
cell growth characteristics after vertical and horizontal implantation in collagen gel. To 
ensure precise delivery of cells in the gel, a guide cannula was used. The tip of the needle 
passed through the guide cannula into the gel. In one set of experiments to achieve 
                                                                                                                                                   21
vertical implantation of cells, the guide cannula was firmly attached to top cover of 6 well 
plates.  A hole was drilled in the cover of the culture plate. The cannula was placed in the 
hole and glued firmly to the side. The same cover was used for all experiments. Each 
time the cover with the guide cannulae was sterilized by dipping in alcohol for 12 hours 
and then exposing to UV light for 1 hour. In another set of experiments the cannula was 
firmly attached to the side of the 6 well plate. This assembly allowed cells to be delivered 
laterally into the gel. Fig. 3 shows a 12 well plate with vertically implanted guide 
cannulas. Fig. 4 shows the infusion assembly used for delivering cells by a needle passed 
through the vertical guide cannula into the gel. Fig. 5 shows a cell culture insert with 
cannula implanted in its lateral aspect. 
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Figure 3. 12 well plate with vertically placed guide cannulae. Collagen gel 
was made in cell culture inserts, which were then placed in the plate. Tip of 
the 25-gauge syringe needle passed through one of the guide cannula into 
collagen gel. 
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Figure 4. Closer view of the 25-gauge syringe needle infusion through 
vertically implanted guide cannula. Cells were infused by the 25-gauge syringe 
needle passing through the guide cannula into collagen gel inserts. This 
assembly allowed identification of baseline characteristics for cell growth in 
gel. 
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Figure 5. Cell culture insert with laterally implanted guide cannula. The cell culture 
insert with the cannula was placed in a 6 well plate. Cell suspension was drawn in a 
needle and tip of the 25-gauge syringe needle passed through the cannula into 
collagen gel. This assembly however resulted in poor cell delivery and growth and 
was not used for prototype catheter experiments. 
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2.12.2 Cell culture experiments using prototype cell delivery catheters   
 By performing the 25 gauge syringe needle cell culture experiments we found that 
type I collagen gel provided a suitable microenvironment for growth of PC12 cells. In 
addition the vertical infusion of cells was found to allow better cell visualization than 
horizontal implantation.   
 Collagen gel was prepared as mentioned above. Collagen was added to cell 
culture inserts of 6 or12 well plates unless specified otherwise and allowed to solidify. 4 
ml of Collagen gel was added to each insert. However 4 ml collagen gel was too dark and 
did not allow good visualization of cells. To overcome this problem we used a sandwich 
gel with 2 ml of collagen gel on the bottom with 2 ml of agarose gel on top. The 
sandwich gel was prepared in 6 well plate inserts. The whole procedure was done in the 
hood with thorough aseptic precautions. PC 12 cells were harvested as per the above- 
mentioned protocols. Cell count was made and diluted to achieve cell count around 1 
million similar to the needle experiments. Both 1.6 mm small bore and 2.0 mm large bore 
catheters were evaluated. Sterilized catheters were primed in the following way. First the 
inner catheter was filled with the cell suspension, and then inserted into the gel along 
with the outer catheter.  We used this combination of inner and outer catheters as our 
agarose gel experiments proved that this combination was least likely to produce air 
bubble and backtracking of agent in the gel. The catheter was attached to a 10 ml syringe 
mounted on a flow rate monitor. The entire assembly was mounted on a stereo tactic 
frame to ensure precise delivery of cells in the gel. The cell culture insert with solidified 
sandwich gel was placed on a lab jack. The tip of the cell suspension primed catheter was 
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inserted in the gel. The infusion was started and continued at a rate of 20 μl / min to 
achieve a uniform cell count delivered to the gel. At the end of three minutes, the infusion 
was stopped and the tip of the catheter was removed from the gel. Similar to the 25 gauge 
syringe needle experiments, the cell culture inserts were kept in an incubator and cell 
growth was followed daily and picture recorded.   The infusion assembly with catheter 
mounted on a frame is shown below in fig. 6 . Figure 7 provides a closer view of the 
catheter with its tip inserted in collagen gel. Table 3 shows a schematic representation of 
cell culture experiments using 25 gauge syringe needle and prototype cell delivery 
catheters. 
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Figure 6. Infusion assembly with 2.0 mm large bore catheter and cell culture 
insert. Collagen gel was prepared in 6 well plate cell culture insert and then 
placed on a lab jack. The catheter was connected to a syringe mounted on a 
flow rate monitor.  
                                                                                                                                                   28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              Figure 7. Closer view of the 2.0 mm large bore catheter tip in cell 
culture insert. Collagen gel was added to the cell culture insert. The 
tip of the catheter was maintained around 1.5 cm below the collagen 
gel surface. 
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Table 3. Schematic representation of cell culture experiments using 25 gauge 
syringe needle and prototype cell delivery catheters. 
 
 
 
 
 
Vertical infusion into gel Horizontal infusion into gel
 Using 25 gauge syringe needle
Neural growth factor added No neural growth factor added
Using prototype cell delivery catheters
Cell culture experiments
 
 
 
 
 
 
 III  Results 
 
 
 
3.1 Dye Experiments  
Dye experiments were carried out as per the procedure mentioned above in 
methods section. Both 1.6 mm small bore and 2.0 mm large bore catheters were 
evaluated using the following 3 combinations of insertion in gel.  In the first combination, 
the inner catheter was filled with dye and inserted into the outer catheter and then into the 
gel. Another set of experiments was conducted with outer catheter inserted and then dye 
filled inner catheter. And finally both inner and outer catheters were inserted in the gel 
and then filled with dye. In addition combinations 2 and 3 were performed with the large 
bore catheter with the inner catheter in locked and unlocked positions. Each type of 
experiment was repeated three times to ensure reproducibility and accuracy. 
Bromophenol blue dye was infused through the catheter for 1 hour to measure air bubble 
production and presence or absence of backtracking of dye. At the end of the infusion 2 
dimensions of air bubbles produced and presence or absence of backtracking of dye were 
noted.   
 
3.1.1 Small bore catheter:  
In the first set of experiments, the inner catheter was first filled with dye and 
inserted into the outer catheter and then into the gel, no air bubble and backtracking of 
30 
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dye were seen. The same results were obtained each time the experiment was repeated. 
Since there was no visible air bubble observed, the mean and SD of air bubble produced 
were estimated as zero. A representative picture of results obtained with this combination 
of insertion of inner and outer catheters is shown in figure 8. Table 4 lists the size of the 
air bubbles in square cm. and the presence or absence of backtracking of dye.
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Catheter 
 
Dye 
Agarose 
gel 
 
Figure 8. Dye experiments with 1.6 mm small bore catheter. Inner catheter 
filled and inserted into outer catheter and then into gel. Note no air bubble or 
backtracking of dye along catheter track.  
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 In the second set of experiments, the outer catheter was initially inserted in 0.6 % 
agarose gel. The inner catheter was primed with the bromophenol blue dye and then 
inserted into the outer catheter. Presence of air leak was noted and the dimensions of air 
bubble were measured. With this combination, an air bubble was consistently observed 
but there was no backtracking of dye noted. The maximum dimensions of the air bubble 
produced were 0.3 x 1.0, 0.6 x 0.8 and 0.5 x 0.8. Air leak inside the brain has been 
associated with multiple complications and is unfavorable. For statistical comparison, the 
product of the maximum dimensions (visible surface area) of the air bubble was 
computed and compared. The mean and standard deviation of the size of the air bubble 
were 0.393 ± 0.09 cm². Fig. 9 shows a representative picture of infusion of gel with this 
combination of catheters. 
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Air 
bubble
 
Figure 9. Dye experiments with 1.6 mm small bore catheter. Outer catheter 
inserted in the gel and then dye filled inner catheter. An air bubble is seen 
without any backtracking of dye. 
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In the third set of experiments, both inner and outer catheters were inserted in gel and 
then filled with bromophenol blue dye. The presence and maximum dimensions of air 
leak and backtracking of dye were measured. The entire experiment was repeated three 
times. An air bubble was consistently seen (1.1 x 1.5, 1.2 x 1.4, and 1.2 x 1.5 cm²) but 
backtracking of dye was seen only once. Mean and standard deviation of the size (visible 
surface area) of the air bubble were 1.71 ± 0.07 cm² respectively.   Size of the air bubble 
produced with this combination was the largest among the 3 combinations tested (p < 
0.05). Backtracking of dye was seen with an air bubble of dimensions 1.1 x 1.5 cm², 
which was not the largest air bubble, observed. The results obtained after dye infusion 
using small bore catheter are presented in tables 4 and 5.   
No air leak and backtracking of dye were noted when the inner catheter was filled 
with dye and then inserted with the outer catheter into the gel. The size of the air bubble 
produced with this combination was significantly smaller than the air bubbles produced 
with the other 2 combinations (p < 0.001). Further studies were conducted with the large 
bore catheter to corroborate these findings.
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Table 4. Dye experiments with 1.6mm small bore catheter. Bromophenol blue dye was 
infused through the small bore catheter and presence and maximum dimensions of air 
bubble produced were measured. Backtracking of dye along the catheter track was also 
noted. 
 
 
Method Size of air bubble 
(cm²) 
Back tracking of 
dye 
0 x 0 Absent 
0 x 0 Absent 
Inner catheter filled 
with dye and 
inserted with outer 
catheter into gel 
0 x 0 Absent 
0.3 x 1.0 Absent 
0.6 x 0.8 Absent 
Outer catheter 
inserted in gel and 
then dye filled inner 
catheter 
0.5 x 0.8 Absent 
1.1 x 1.5 Present 
1.2 x 1.4 Absent 
Both inner & outer 
catheters inserted in 
gel & then filled 
with dye 
1.2 x 1.5 Absent 
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Table 5.Graph of results of dye experiments with 1.6 mm small bore catheter. Table 
shows size of air bubble produced with different combinations of insertion of inner 
and outer catheters.  
* Legend for combinations of insertion in dye of inner and outer catheters: 
1 = Inner catheter filled with dye and inserted with outer catheter into gel 
2 = Outer catheter inserted in gel and then dye filled inner catheter 
3 = Both inner & outer catheters inserted in gel & then filled with dye 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Size of 
air bubble
 in sqcm
1 2 3
Combination of insertion in dye of inner and outer catheters*
Mean air bubble produced with small bore cathter using different 
combinations of outer and inner catheters
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3.1.2 Large 2.0 mm bore catheter 
The 2.0 mm large bore catheters were evaluated using the same 3 combinations of 
inner and outer catheters like with the 1.6 mm small bore catheter. In the first 
combination, the inner catheter was filled with dye and inserted into the outer catheter 
and then into the gel. In combination 2, the outer catheter inserted and then dye filled 
inner catheter. And finally both inner and outer catheters were inserted in gel and then 
filled with dye.  In addition for combinations 2 and 3, the inner catheter was kept in 
locked or unlocked positions. Each experiment was repeated 3 times.  
In combination 1, the inner catheter was filled with dye, inserted into the outer 
catheter and then inserted into the 0.6% agarose gel. Since the inner catheter was filled 
with dye before inserting in gel, it allowed the air between the inner and outer catheters to 
escape to the outside. We recognized that keeping the inner catheter locked or unlocked 
would not contribute to air bubble formation in gel, as the air would have already escaped 
between the catheters before insertion in gel.  Similar to the results obtained with the 1.6 
mm small-bore catheter, we found no air bubble and no back tracking of dye (table 6). 
The mean and standard deviation for size of air bubble were both zero cm². Using 
ANOVA analysis, we found the size of air bubble with this combination was significantly 
smaller than the air bubble produced with the other 2 combinations (p <0.001). This 
combination proved to have the potential for eliminating the problems of air leak and 
backtracking of dye and because of this we decided to use this combination for cell 
delivery as described in subsequent sections.  
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Table 6. Results of dye experiments with 2.0 mm large bore catheters with inner catheter 
filled with dye and then inserted with outer catheter into gel. 
 
 
Method Size of air bubble 
(cm²) 
Back tracking of 
dye 
0 x 0 Absent 
0 x 0 Absent 
 
Inner catheter filled 
with dye and 
inserted with outer 
catheter in gel 0 x 0 Absent 
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In the second set of experiments, we inserted the outer catheter into the gel prior to 
inserting a dye filled inner catheter into the outer catheter. The position of the inner 
catheter was kept locked for 3 experiments and unlocked for another 3 experiments. We 
had hypothesized that the unlocked position of the inner catheter would allow air to 
escape between the catheters and prevent the air from going into the gel. However we 
found that an air bubble was produced in each experiment irrespective of the locked or 
unlocked position of the inner catheter. The maximum dimensions of air bubble produced 
with the inner catheter in locked position were 0.5 x 0.6, 0.4 x 0.4, 0.4 x 0.5 cm² and with 
the inner catheter unlocked were 0.1 x 0.1, 0.2 x 0.5, 0.6 x 1.2 cm² respectively (see table 
7).  The mean size of air bubble (surface area visible) with the inner catheter in locked 
position (0.22 ± 0.07 cm²) did not differ significantly (p = 0.70) with the mean air bubble 
size (0.30 ± 0.35 cm²) with the inner catheter in unlocked position. No backtracking of 
dye was seen in either position of the inner catheter (see table 7 and fig. 10).  
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Table 7. Results of dye experiments with 2.0 mm large bore catheters with outer catheter 
inserted and then dye filled inner catheter. An air bubble was consistently seen but no 
backtracking of dye was seen. 
 
Method Inner catheter Air bubble 
(cm²) 
Back tracking 
Locked 0.5 x 0.6 Absent 
Locked 0.4 x 0.4 Absent 
Locked 0.4 x 0.5 Absent 
Unlocked 0.1 x 0.1 Absent 
Unlocked 0.2 x 0.5 Absent 
 
 
 
Outer catheter 
inserted and 
then dye filled 
inner catheter 
Unlocked 0.6 x 1.2 Absent 
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 Air bubble 
 
 
 
Figure 10. Dye experiments with 2.0 mm large bore catheter. Outer catheter 
inserted and then dye filled inner catheter in unlocked position. Note air 
bubble produced without any backtracking of dye.  
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The third combination for large bore catheter consisted of insertion of both the tubes in 
0.6% agarose gel and then infusing bromophenol blue dye into the inner tube. The inner 
catheter was kept locked or unlocked inside the outer catheter. An air bubble was 
consistently seen irrespective of the locked or unlocked position of the inner catheter. The 
maximum dimensions of the air bubble produced with the inner catheter locked were 0.7 
x 1.1, 0.6 x 0.4, 0.6 x 2.0 cm² and with the inner catheter unlocked were 0.2 x 0.2, 1.5 x 
2.0, 0.4 x 0.7 cm² respectively (see table 8). The mean size of air bubble with the inner 
catheter in locked position (0.73 ± 0.48 cm²) did not differ significantly (p = 0.72) from 
the mean size of air bubble produced with the inner catheter in unlocked position (1.1 ± 
1.6 cm²). However, backtracking of dye was only seen when the inner catheter was 
locked (see fig. 11). This could be due to fact that the locked position of the inner 
catheter did not allow air to escape. This air was forced to escape in the gel. Table 9 
summarizes the findings after dye infusion through 2.0 mm large bore catheter. 
In all the dye experiments with 1.6 mm small bore and 2.0 mm large bore catheter 
backtracking of dye was noted only when an air bubble was produced. However not 
every air bubble, nor size of air bubble correlated with backtracking of dye. Size of air 
bubble produced did not correlate with presence of backtracking. Keeping the inner 
catheter of the catheter locked did not prevent air leak. Our dye experiments confirmed 
that when the inner catheter was filled with gel, inserted in the outer catheter and then 
into the gel, no air leak and backtracking of dye were observed. This combination had the 
potential to eliminate the problem of introducing air during neurosurgery. 
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 Table 8. Results of dye experiments with 2.0 mm large bore catheter with both inner and 
outer catheters inserted in gel and then filled with bromophenol blue dye. 
 
 
Method Inner catheter Air bubble 
(cm²) 
Back tracking 
Locked 0.7 x 1.1 Present 
Locked 0.6 x 0.4 Present 
Locked 0.6 x 2.0 Present 
Unlocked 0.2 x 0.2 Absent 
Unlocked 1.5 x 2 Absent 
 
 
 
Both inner and 
outer catheters 
inserted and 
then filled 
Unlocked 0.4 x 0.7 Absent 
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Figure 11. Dye experiments with 2.0 mm large bore catheter. Both inner and 
outer catheters inserted and then filled (tight fit). Note presence of air bubble 
and backtracking of dye.  
Backtracking 
of dye 
Air bubble 
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Table 9. Graph of results of dye experiments with 2.0 mm large bore catheter. Table 
shows size of air bubble produced with different combinations of insertion of inner 
and outer catheters.  
* Legend for combinations of insertion of inner and outer catheters in dye: 
1 = Inner catheter filled with dye and inserted with outer catheter into gel 
2 = Outer catheter inserted in gel and then dye filled inner catheter in locked 
position 
3 = Outer catheter inserted in gel and then dye filled inner catheter in unlocked 
position 
4 = Both inner & outer catheters inserted in gel & then filled with dye in locked         
position 
5 = Both inner & outer catheters inserted in gel & then filled with dye in unlocked     
 
  
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
Size of  
air bubble 
 in sqcm 
1 2 3 4 5 6 7 
Combination of inner and outer catheters* 
Mean size of air bubble produced with 2.0 mm large bore catheter using 
different combinations of inner and outer catheters
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3.2  Cell Culture experiments 
3.2.1 Needle Experiments  
A series of cell infusion experiments were carried out using a 25-gauge syringe 
needle to optimize the microenvironment conducive for cell growth prior to catheter 
infusions. These experiments allowed determining the number of cells, quantity of gel, 
type of culture plate, inserts and growth factors. Pheochromocytoma (PC12) cells were 
infused through a 25-gauge syringe needle into collagen gel.  
In the first set of experiments with a 25 gauge syringe needle, the tip of the needle 
was inserted directly into the collagen gel (made in a 6 well plate insert) and kept around 
1.5 cm below the gel surface. The 25-gauge syringe needle was connected to a flow rate 
monitor and mounted on a stereo tactic assembly as mentioned in methods. Cell (conc. 1 
million / cm³) were infused at a rate of 20 μl /min and continued for 3 min. The growth of 
cells was followed for a period of one week.  We noted good cell growth after infusion of 
cells by the 25 gauge syringe needle. These experiments were repeated three times and 
cell growth was seen after each infusion. We conclude that PC12 cells at a concentration 
of 1 million / μl delivered by a 25 gauge syringe needle into collagen gel in a 6 well plate 
showed good growth potential. Figs.12 to14 show cell growth after 25 gauge syringe 
needle infusion in collagen gel. 
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Figure 12. Infusion of PC12 cells by 
needle in collagen gel (Day 1). The 
central crater is created by the needle 
insertion in gel. Cells were infused 
through the needle. Cells spread on and 
below the surface of the gel and are 
visualized using high power microscopy 
(40X). 
 
 
 
 
Figure 13. Infusion of PC12 cells by 25 
gauge syringe needle in collagen gel (Day 
3). The cells appear to increase in number. 
40X magnification. 
 
 
 
Figure 14. Infusion of PC12 cells by 25 
gauge needle in collagen gel (Day 7). The 
cells continue to visibly increase in 
number. The collagen gel provided 
suitable microenvironment for growth of 
cells and also allowed their visualization. 
40X magnification. 
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The 25 gauge syringe needle experiments confirmed that collagen gel provided a 
favorable medium for growth of PC12 cells in our lab. This provided vital background 
information for future studies with prototype catheters. 
Additional cell infusion experiments were carried out using the 25 gauge syringe 
needle. The tip of the 25 gauge syringe needle was passed through a plastic guide cannula 
to ensure precise delivery of cells in the gel. The aim of the cannula experiments was to 
study cell growth patterns after vertical and lateral infusion of cells.  
            To study the growth of cells after vertical implantation in gel, a guide cannula was 
firmly implanted in the cover (lid) of the culture plate as mentioned earlier in methods 
section. The tip of the 25 gauge syringe needle was filled with PC12 cell suspension (1 
million / μl) and infused through the vertically implanted guide cannula into the gel. The 
infusion was started at 1 μl /min and kept running for 3 mins. After dissembling, the cell 
growth in 6 well plate was followed over a period of 1 week. We observed a migration of 
cells towards the periphery. We conclude that cells infused vertically exhibited good 
growth and visualization of cell growth was also technically feasible (figures 15, 16 and 
17). 
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Figure 15. Infusion of PC12 cells by 25 
gauge syringe needle passed through vertical 
guide cannula on day1. Note spherical shape 
of the crater created by the needle. Cells 
were infused at a concentration of 1 
million/μl and continued for 5 mins. 40X 
magnification. 
 
 
 
 
Figure 16. Infusion of PC12 cells by 25 gauge 
syringe needle passed through vertical guide 
cannula on day 3. The cells appear to have 
migrated away from the center. 40X 
magnification. 
 
 
 
Figure 17. Infusion of PC12 cells by 25 
gauge syringe needle passed through 
vertical guide cannula on day 7. Note cell 
migration. This method of cell infusion was 
found to be most favorable and was used to 
evaluate prototype cell delivery catheters. 
40X magnification. 
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Another set of experiments were conducted to study the growth and migration potential 
of cells after lateral implantation in gel. Collagen gel was prepared in 6 well cell culture 
inserts as described above. The tip of the 25-gauge needle was inserted through the 
laterally implanted guide cannula into the 6 well plate. Cell growth and migration were 
followed over 1 week. Infusion through laterally implanted cannula revealed poor visible 
cell growth and migration (figs. 18 and 19). Taking cross sections of the gel and staining 
might provide more information on the patterns of cell growth after lateral implantation. 
The cells however showed excellent migration and growth potential with vertical 
implantation as mentioned earlier. For testing the prototype cell delivery catheters 
experiments we used vertical infusion delivery.
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Figure 18. Infusion of PC12 cells by a 
25 gauge syringe needle passed 
through laterally implanted guide 
cannula into collagen gel (day1).   
 
 
 
Figure 19. Infusion of PC12 cells by a 25 
gauge syringe needle passed through 
laterally implanted guide cannula into 
collagen gel (day7).  Note poor visible 
cell growth after lateral implantation. This 
method of infusion was unfavorable and 
was not used to evaluate prototype 
catheters. 
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3.2.2 Cell culture experiments with prototype cell delivery catheters                                                          
The prototype cell delivery catheters are longer than the 25 gauge syringe needle and 
have 4 spiral side pores as opposed to a single beveled opening in the needle. To 
minimize the development of air bubble and backtracking of dye, the inner tube was 
filled with the cell suspension and then inserted with the outer tube. Our agarose gel 
experiments had indicated that this combination was least likely to produce an air leak 
and backtracking. Preliminary experiments using 2 ml and 4 ml of collagen gel in the 6 
well plate resulted in poor cell growth in the 2 ml gel and poor cell visualization in the 4 
ml gel insert. To overcome these problems we used a sandwich gel of 0.1% agarose and 
collagen gels. The optimum quantity of each gel was found to be 2.5 ml. We used 0.1% 
agarose as it is transparent and solidifies faster than 0.6% agarose. Agarose gel neither 
favors nor hampers cell growth.                                                                                        
PC12 cells (1 million / μl) were infused in each experiment. The catheters (both small 
and large bore) were attached to a flow rate monitor and cells were infused at a rate of 1 
μl / min for 3 min. Cell growth was noted over a period of a week. We used 2 
combinations of sandwich gel. We observed no significant cell growth when collagen gel 
was layered on top of agarose gel, 5 days after infusion. This combination did not provide 
a good environment for cell growth. The experiments were repeated 3 times to ensure 
reproducibility. When agarose gel was layered on top of collagen, we observed cell 
growth. The lower layer of collagen favored cell growth while the upper layer of 0.1% 
agarose allowed cell visualization. We repeated these experiments three times to confirm 
the findings. Both 1.6mm small bore and 2.0mm large bore catheters were evaluated. 
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Similar results were obtained after each experiment. Figures 20-22 show representative 
pictures of results obtained after PC12 cell infusion through prototype catheters into 
sandwich gel.   
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Figure 20. Large bore catheter infusion of 
PC12 cells with 0.1 % agarose gel on top of 
collagen gel, day 1. Note central cluster of 
cells and some migration around the 
periphery. Also note size of the crater created 
by catheter infusion was significantly larger 
than that made by the needle. 40X 
magnification. 
 
 
 
Figure 21. Large bore catheter infusion of 
PC12 cells with 0.1 % agarose gel on top of 
collagen gel, day 3. 40X magnification. 
 
 
 
 
Figure 22. Large bore catheter infusion of PC12 
cells with 0.1 % agarose gel on top of collagen 
gel, day 7. The prototype cell delivery catheters 
delivered PC12 cells into a sandwich gel with 
collagen gel on top and the cells appear to grow.  
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3.2.3 Neural Growth Factor 
GF) is known to promote differentiation of PC 12 cells in 
culture
act 
n 
re 
rts 
d 
 
 
ers. 
Neural growth factor (N
 (52, 53). We wanted to test if NGF could differentiate PC12 cells following 
infusion using the prototype cell delivery catheters. This would have significant imp
on the role of catheters for cell replacement strategies in which growth and differentiatio
factors could be delivered at some point following the infusion of cells. Both 1.6 mm 
small bore and 2.0 mm large bore catheters were used for cell delivery. Sandwich gel 
(0.1%agarose on top of collagen) was prepared in 4 cell culture inserts. PC 12 cells we
infused at a concentration of 1 million / μl into sandwich gel in each of the 4 inserts 
separately. The duration of infusion in each insert was 3 mins. The 4 cell culture inse
were placed in a 6 well plate. A dilute concentration of NGF was prepared. The NGF 
solution was then added to 2 inserts and culture medium to another 2 inserts that serve
as control. Cell growth and most notably differentiation were recorded over a period of 4
days. We found significant differentiation of cells treated with NGF (figures 23 and 24) 
as opposed to controls. Within 2 days the cells with NGF were developing axons. When 
cells were delivered in the sandwich gel by catheters and NGF was not added, no cell 
differentiation was noted (fig. 25). The cells continued to grow but didn’t develop into
neurons. The entire experiment was repeated three times to ensure reproducibility. 
Similar results were obtained after cell infusion through small and large bore cathet
Cells delivered by the prototype cell delivery catheters had the potential to differentiate 
into neurons in the presence of NGF. 
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Figure 23. NGF added to sandwich gel after 
delivering PC12 cells with prototype catheter 
(day 1).  
 
Figure 24. NGF added to sandwich gel after 
delivering PC12 cells with prototype catheter 
 
g 
(day 4). Note excellent differentiation of cells
into neurons. Axons and dendritic processes 
are visible. This experiment showed that 
PC12 cells delivered by the prototype 
catheters had the potential of differentiatin
into neurons in the presence of NGF.  
 
Figure 25. No NGF added to sandwich gel 
after delivering PC12 cells with prototype 
 catheter (day 4). Note lack of differentiation
of cells in the absence of NGF.  
 
 IV  Discussion and Conclusions 
 
 
 
4.1 Discussion 
 Neurodegenerative diseases including Parkinson’s disease and Alzheimer’s 
disease are prevalent worldwide. Medical treatment of these disorders is associated with 
complications and after a few years many patients fail to respond to therapy. Intracranial 
therapy of stem cells, drugs and growth factors has the potential to cure these diseases. 
There have been reported promising results following stem cell transplantation, 
dopaminergic producing cells and gene therapy for Parkinson's disease (55, 56).Wang, et 
al. showed that transplantation of neural stem cells into the prefrontal and parietal 
cortices of dementia induced mice, dramatically alleviated the cholinergic deficits and 
recent memory disruption (57). 
 Glioblastoma multiforme (GBM) is the most common and aggressive type of 
primary brain tumor, accounting for 52 percent of all primary brain tumor cases and 20 
percent of all intracranial tumors (26, 27). Treatment can involve chemotherapy, 
radiotherapy and surgery; all of which are considered as palliative measures as they 
rarely provide a cure (58). There is extensive literature on the use of intracranial 
chemotherapy in the treatment GBM. Many new experimental protocols are under 
investigation. Pellagatta, et al demonstrated that intracranial injection of dendritic cells 
58 
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increased survival in mice bearing intracranial glioblastomas (59). Aghi, et al reviewed 
the usefulness of gene therapy for improving survival in patients with GBM (60). In 
addition to these novel mo ies ogenesis factors and 
r investigation (61, 62, 63). 
Several techniques have been developed for delivering agents directly to the 
brain. Implantable miniature osmotic pumps, implantable microporous devices and 
er infusion pressures, damage of tissues due to local 
 
t be 
nd 
dalit  infusion of cytokines, antiangi
monoclonal antibodies are unde
 
macroencapsulation are some of the techniques for intracranial therapy. However results 
with these modalities have been variable. The prototype cell delivery catheters provide a 
novel method for delivering stem cells, drugs and growth factors into the brain 
parenchyma. Intracranial therapy offers the hope for potential cure of neurodegenerative 
disorders and brain tumors. The major advantage of intracranial therapy is the ability to 
overcome the blood brain barrier and achieve very high concentration of therapeutic 
agents inside the brain while minimizing systemic side effects. Air leakage during 
catheter infusion creates a significant problem during neurosurgery including 
backtracking of agent, need for high
pressure and rarely air embolism all of which may increase morbidity and mortality. 
Backtracking of therapeutic agents is undesirable as it not only reduces the concentration
of agents at the intended site but also increases it at an unintended site. This migh
particularly important during delivery of stem cells for neurodegenerative disorders a
delivery of cytotoxic drugs in localized brain tumors (64, 65).  
 We evaluated prototype cell delivery catheters aimed to reduce the above 
mentioned complications. Each catheter has an inner catheter with one end pore and an 
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outer catheter with 4 spiral pores. Small bore (1.6 mm outer catheter) and large bore (2.0
mm outer catheter) catheters were evaluated using 0.6 % agarose gel and collagen ge
experiments.  
          The 0.6 % agarose gel experiments were conducted to
 
l 
 study the presence or 
y 
 
 
ked and 
en 
e 
ative of air 
ble 
 
periments. 
esults. 
r 
absence of air leak and backtracking of dye after infusion of bromophenol blue dye b
the catheters. Chen et al. has shown that 0.6 % agarose gel in brain box simulates the
diffusion characteristics of the human brain (41). The small and large bore catheters were
evaluated using 3 combinations of insertion of inner and outer catheters in the gel. The 
2.0 mm large bore catheter in addition was evaluated with the inner catheter loc
unlocked inside the outer catheter.    
 The agarose gel experiments using the 1.6 mm small bore catheter demonstrated 
that when the inner catheter was filled with dye, inserted into the outer catheter and th
into gel, no air bubble or backtracking of dye was seen. Using ANOVA analysis, w
showed that this combination had significantly smaller size of air bubble indic
leakage as compared to the other 2 combinations. Therefore this combination has the 
potential to eliminate the problems associated with air leak during surgery. An air bub
was consistently seen but there was no backtracking of dye when the outer catheter was 
inserted in gel prior to the insertion of a dye filled inner catheter. When both inner & 
outer catheters were inserted in gel & then filled with dye, an air bubble was consistently
observed but backtracking of dye was seen in only 1 out of 3 ex
 The agarose gel experiments with 2.0 mm large bore catheter had similar r
When the inner catheter was filled and inserted with outer catheter, again no air bubble o
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backtracking was observed. ANOVA analysis showed that the size of air bubble was 
significantly smaller with this combination of inner and outer tubes than the other 
combinations. Due to this reason, all cell culture experiments were conducted with this 
er 
e 
lways observed. However in this paradigm, 
en 
yringe needle 
combination of inner and outer catheters. The inner catheter of the large bore cathet
was kept either locked or unlocked for the other 2 combinations of inner and outer 
catheters. When the outer catheter was inserted in 0.6% agarose prior to insertion of dy
filled inner catheter, irrespective of the lock between the 2 catheters (locked, unlocked) 
an air bubble was consistently seen. There was no backtracking of dye. In the third 
combination when both inner & outer catheters were inserted in gel & then filled with 
bromophenol dye, an air bubble was a
backtracking of dye was noted only when the inner catheter was locked inside the outer 
catheter. This could be due to the fact that the locked position of the catheters, does not 
allow air to escape to the outside and it forces air to pass through the spiral pore into the 
gel.  
 In all the 0.6% agarose gel experiments, backtracking of dye was seen only wh
an air bubble was produced. Size of the air bubble did not correlate with backtracking of 
dye. Further studies are needed to explore this phenomenon in detail. The timing and 
position of air bubble produced might be associated with the development of 
backtracking of dye.  
 Cell culture experiments were initially performed using a 25 gauge s
to deliver pheochromocytoma cells (PC12) in collagen gel to optimize the baseline 
characteristics for cell growth and differentiation prior to using catheters. We found that 
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PC12 cells at a concentration of 1 million / μl delivered by a 25 gauge syringe needle 
a collagen gel in a 6 well plate demonstrate growth of cells. These characteristics s
as a good baseline for the catheter experiments. The 25 gauge syringe needle experimen
proved that the collagen gel and microenvironment were conducive for cell growth. 
 Another set of experiments were performed to compare vertical and lateral 
infusion using a 25-gauge syringe needle passing through a cannula into collagen gel. 
The cannula was inserted either vertically or laterally in a 6 well culture plate. We 
observed that visualization of cell growth was better after vertical delivery as oppose
lateral delivery. This phenomenon could be due to actual decreased cell growth or poor
visualization after lateral delivery. Taking cross sections and staining might help in
understanding this process.  
 Next we tested the prototype catheter found to be optimal for its lack of creating 
cathe
into 
erved 
ts 
d to 
 
 better 
air bubbles and backtracking to deliver cells vertically into a collage gel.  The inner 
ter was primed with PC12 cells, inserted into the outer catheter prior to insertion of 
was 
arose gel at the top and collagen gel at the bottom. PC12 cell 
into a collagen gel.  We observed minimum cell growth in 4 ml collagen gel. This was 
probably due to difficult visualization as 4 ml of collagen gel is not transparent. To 
overcome this problem we used a sandwich-type gel in which 2 ml of collagen was 
overlaid with 2 ml of 0.1 % agarose, which is transparent. Visible cell growth 
observed with 0.1% ag
infusion experiments were performed with the 1.6 mm small bore and 2.0 mm large bore 
catheters and consistent cell growth in sandwich gel was noted.   
 PC12 cells are known to differentiate in the presence of neural growth factor (51, 
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52). Using 1.6 mm small bore and 2.0 mm large bore catheters, PC12 cells were 
vertically infused into collagen gel.  Neural growth factor was added to 2 inserts and the 
other 2 inserts served as controls. We observed significant differentiation of cells treated 
with NGF as opposed to controls. Within 4 days, the cells had developed axonal and 
dendritic-like processes.  PC12 cells delivered by this prototype cell delivery cathet
have the potential to grow and differentiate in the presence of NGF. Further studies wit
cell infusion and then NGF infusion through the prototype catheters would provide 
information on the utility of catheters for cell delivery and differentiation.  
 
4.2 Conclusions  
 The prevalence of neurodegenerative diso
er 
h 
more 
rders and brain tumors is increasing. 
. 
hich 
 of 
 catheters showed good 
The Blood Brain Barrier (BBB) is a significant obstacle to the delivery of therapeutic 
agents to the brain administered systemically. These diseases would benefit from 
intracranial therapy. This method of treatment bypasses the BBB and allows direct 
delivery of therapeutic agents into the brain at the same time minimizing systemic side 
effects. We tested prototype cell delivery catheters using dye and cell culture models
With a primed inner catheter, minimal air leak and backtracking of dye was noted w
would be beneficial during neurosurgical based treatments. Baseline characteristics
cell growth were optimized using cell infusion experiments with a 25 gauge syringe 
needle. The prototype cell delivery catheters demonstrate potential for delivering cells in 
collagen gel. PC12 cells delivered through prototype cell delivery
differentiation in the presence of NGF. The common problems with neurosurgical 
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catheters are air leakage following catheter insertion and consequences secondary
including tissue damage. Our studies show that the prototype cell delivery catheters 
tested could be used to overcome these problems during neurosurgery. Further studies 
including quantification of cell growth, migration of cells after delivery, infusion of 
growth factors and growth inhibitors through the catheters might shed more light on th
therapeutic agent delivering potential of these catheters.  
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